EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Ashwagandha: Is It Safe? Part 1: A Regulatory Review

T Brendler iD, R Al-Mondhiry, L Lang, R Marles, M Tallon, A Raghu

Phytotherapy Research · 2026-08 · 40 (8) · 4845-4857

DOI: 10.1002/ptr.70151 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, published online on 2025-12-19. Written by T Brendler and 5 co-authors. Institution: Department of Botany and Plant Biotechnology, University of Johannesburg, Johannesburg, South Africa. Major MEDLINE topics: Withania, Dietary Supplements. Cited 8 times so far (Crossref); 58 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Over the last decade, ashwagandha ( Withania somnifera (L.) Dunal, AS) has been brought under increasing scrutiny by EU regulators regarding its safety for the use in food supplements, culminating in a recent recommendation for an Article 8 procedure according to Regulation (EC) No. 1925/2006 in the European Union (EU). Once executed, this could lead to a ban on its use as an ingredient in food supplements. This review summarizes how AS is regulated in some of the primary world marketplaces.

Subjects

MeSH terms (MEDLINE)

WithaniaDietary SupplementsEuropean UnionHumansAnimalsPlant Extracts

Author keywords

Withaniaadaptogenashwagandharegulationssafety

Substances

AshwagandhaPlant Extracts

Authors and institutions

  • Department of Botany and Plant Biotechnology, University of Johannesburg, Johannesburg, South Africa.
  • Pharmacognosy Institute, School of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.
  • Amin Wasserman Gurnani LLP, Washington, District of Columbia, USA.
  • Complementary Medicines Australia, Mawson, Australian Capital Territory, Australia.
  • Health Products and Food Branch, Health Canada, Ottawa, Ontario, Canada.
  • Legal Foods Ltd., Ely, Cambridgeshire, UK.

ORCID profiles: T Brendler

Cite

APA

Brendler, T., Al-Mondhiry, R., Lang, L., Marles, R., Tallon, M., & Raghu, A. (2026). Ashwagandha: Is It Safe? Part 1: A Regulatory Review. Phytotherapy Research, 40(8), 4845-4857. https://doi.org/10.1002/ptr.70151

Vancouver

Brendler T, Al-Mondhiry R, Lang L, Marles R, Tallon M, Raghu A. Ashwagandha: Is It Safe? Part 1: A Regulatory Review. Phytotherapy Research. 2026;40(8):4845-4857. doi:10.1002/ptr.70151

BibTeX
@article{Brendler2026,
  author = {Brendler, T and Al-Mondhiry, R and Lang, L and Marles, R and Tallon, M and Raghu, A},
  title = {Ashwagandha: Is It Safe? Part 1: A Regulatory Review},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {8},
  pages = {4845--4857},
  doi = {10.1002/ptr.70151}
}
Start for free →